In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

The U.S. flu season is starting slowly, and it’s not clear if it will be as bad as last winter’s. But some health experts are ...

California could see an early and especially sharp start to the annual flu season, as a combination of low vaccination rates ...

While flu levels are still low, a strain that's wreaked havoc in the U.K. and Canada is behind most cases so far in the U.S., ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

Students on and near campus discussed their views on vaccines after BYU’s various vaccine clinics and initiatives.

HealthDay News — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in the ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune ...

Board-certified rheumatologist Dr. Mahsa Tehrani explains how the H3N2 flu strain could affect the upcoming winter season on ...